Kolmar Korea Co.

HK inno.N has raised more than $500m in an initial public offering on the Kosdaq market, joining the club of major biopharma IPOs in South Korea. The company was formerly known as CJ Healthcare and i

While COVID-19-related deals have largely dominated the global biopharma industry this year, the alliances reached by South Korean companies in the sector in 2020 ranged widely, from oncology to non-a

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. China Grand Alliance With eTheRNA Follo

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in